Acute nonvariceal upper gastrointestinal hemorrhage

被引:11
作者
Grace H. Elta
机构
[1] University of Michigan,Division of Gastroenterology
关键词
Peptic Ulcer; Omeprazole; Peptic Ulcer Disease; Injection Therapy; Thermal Therapy;
D O I
10.1007/s11938-002-0062-6
中图分类号
学科分类号
摘要
Upper endoscopy to assess the risk of rebleeding in patients with nonvariceal upper gastrointestinal bleeding may be used for triage, allowing outpatient care of selected patients and leading to significant cost savings.Over the last 10 years, hospitalization days required for upper gastrointestinal bleeding have decreased significantly and the majority of patients with upper gastrointestinal bleeding undergo endoscopy within 24 hours of admission. Twenty percent to 35% of these endoscopies include endoscopic hemostatic therapy.Endoscopic treatment is recommended for actively bleeding (ie, spurting or oozing) visible vessels and nonbleeding visible vessels that are raised and cannot be washed off.Endoscopic methods can be divided into thermal (multipolar coagulation, heater probe, argon plasma coagulator, Nd:YAG laser) and nonthermal (eg, injection therapy); both types are effective. A combination of injection and thermal therapy with initial injection to slow the bleeding or ”clear the field” followed by coagulation of the identified vessel is popular.Bleeding recurs in 15% of patients. A recent randomized controlled trial of repeat endoscopic treatment versus surgery for patients with recurrent ulcer bleeding concluded that endoscopic retreatment is superior to surgery.Most peptic ulcer rebleeding occurs within the first 3 days of presentation. A comparison of omeprazole and placebo therapy in high-risk ulcer patients with bleeding stigmata at endoscopy who were not treated endoscopically found that highdosage omeprazole (40 mg twice a day) significantly lowered the rates of further bleeding and surgical intervention. Although unlikely to replace endoscopic therapy, this study demonstrated the efficacy of potent acid suppression, perhaps due to stabilization of clotting activity. A recent placebo-controlled trial of high-dosage parenteral omeprazole after endoscopic treatment of bleeding peptic ulcers demonstrated a substantial reduction in the risk of rebleeding.
引用
收藏
页码:147 / 152
页数:5
相关论文
共 92 条
[1]  
Longstreth GF(1995)Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study Am J Gastroenterol 90 206-210
[2]  
Pahor M(1996)Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old Lancet 347 1061-1065
[3]  
Guralnik JM(2000)Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding N Engl J Med 343 834-839
[4]  
Furberg CD(1996)Care of patients with upper gastrointestinal hemorrhage in academic medical centers: a community based comparison Gastroenterology 111 385-390
[5]  
Lanas A(1996)Risk assessment after upper gastrointestinal haemorrhage Gut 38 316-321
[6]  
Bajador E(1981)The National ASGE Survey, on upper gastrointestinal bleeding Gastrointest Endosc 27 73-79
[7]  
Serrano P(1986)Nature of the bleeding vessel in recurrently bleeding gastric ulcers Gastroenterology 90 595-608
[8]  
Cooper GS(1990)Endoscopic risk factors for bleeding peptic ulcer Gastrointest Endosc 36 S16-20
[9]  
Chak A(1985)Endoscopic prediction of major rebleeding—a prospective study of stigmata of hemorrhage in bleeding ulcer Gastroenterology 88 1209-1214
[10]  
Harper DL(1979)The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage N Engl J Med 300 1411-1413